Terms: = Thyroid cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
7 results:
1. Genomic Characteristics and Its Therapeutic Implications in Breast cancer Patients with Detectable Molecular Residual Disease.
Zhang S; Jiang Y; Zhou L; Xu J; Zhang G; Shen L; Xu Y
Cancer Res Treat; 2024 Apr; 56(2):538-548. PubMed ID: 38062709
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing map3k1 and activating autophagy.
Dai L; Zhang W; Wu X; Zhou S
J Clin Lab Anal; 2022 Jun; 36(6):e24470. PubMed ID: 35524422
[TBL] [Abstract] [Full Text] [Related]
3. Identification of the risk factors of the thyroid cancer by using logit model in Lahore.
Asif F; Noor-Ul-Amin M; Ahmad MR
Pak J Pharm Sci; 2018 Nov; 31(6):2391-2396. PubMed ID: 30473509
[TBL] [Abstract] [Full Text] [Related]
4. Mutation screening of 10 cancer susceptibility genes in unselected breast cancer patients.
Xie Y; Li G; Chen M; Guo X; Tang L; Luo X; Wang S; Yi W; Dai L; Wang J
Clin Genet; 2018 Jan; 93(1):41-51. PubMed ID: 28580595
[TBL] [Abstract] [Full Text] [Related]
5. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast cancer.
Neugut AI; Zhong X; Wright JD; Accordino M; Yang J; Hershman DL
JAMA Oncol; 2016 Oct; 2(10):1326-1332. PubMed ID: 27281650
[TBL] [Abstract] [Full Text] [Related]
6. Mitogenic effect of orphan receptor TR3 and its regulation by mekk1 in lung cancer cells.
Kolluri SK; Bruey-Sedano N; Cao X; Lin B; Lin F; Han YH; Dawson MI; Zhang XK
Mol Cell Biol; 2003 Dec; 23(23):8651-67. PubMed ID: 14612408
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract] [Full Text] [Related]
